Axiom-4 astronauts will study insulin and glucose behavior in microgravity aboard the ISS. Led by Burjeel Holdings and Axiom Space, the mission includes continuous glucose monitoring and testing insulin pens. The research aims to improve diabetes care, especially for patients with limited mobility, and could advance wearable tech and personalised treatments.